|
|
neuronal action potential
|
GO:0019228 |
54 |
0.491
|
|
|
|
negative regulation of ovulation
|
GO:0060280 |
1 |
0.430
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.394
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.389
|
|
|
|
negative regulation of metanephric glomerulus development
|
GO:0072299 |
1 |
0.327
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.324
|
|
|
|
adrenal cortex development
|
GO:0035801 |
2 |
0.322
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.319
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.293
|
|
|
|
adrenal cortex formation
|
GO:0035802 |
2 |
0.238
|
|
|
|
negative regulation of metanephric glomerular mesangial cell proliferation
|
GO:0072302 |
1 |
0.233
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.229
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.213
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.181
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.178
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.175
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.171
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.169
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.166
|
|
|
|
metanephric part of ureteric bud development
|
GO:0035502 |
2 |
0.157
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.156
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.156
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.149
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.142
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.141
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.137
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.135
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.135
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.132
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.123
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.117
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.116
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.116
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.113
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.113
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.111
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.110
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.109
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.108
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.107
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.107
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.106
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.103
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.102
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.102
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.102
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.102
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.100
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900211 |
4 |
0.100
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.099
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.098
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.097
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.097
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.096
|
|
|
|
protein export from nucleus
|
GO:0006611 |
20 |
0.096
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.095
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.095
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.093
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.092
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.092
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.092
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.091
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.091
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.090
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.090
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.089
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.089
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.088
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.087
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.087
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.086
|
|
|
|
rhombomere 3 formation
|
GO:0021660 |
1 |
0.086
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.084
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.084
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.084
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.084
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.083
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.083
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.083
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.081
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.081
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.081
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.080
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.078
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.076
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.075
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.075
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.074
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.074
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.074
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.073
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.073
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.073
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.073
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.071
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.071
|
|
|
|
rhombomere 3 morphogenesis
|
GO:0021658 |
2 |
0.071
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.071
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.069
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.069
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.069
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.068
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.068
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.067
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.067
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.066
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.066
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.066
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.066
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.066
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.065
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.065
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.065
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.065
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.063
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.063
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.063
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.063
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.063
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.062
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.061
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.061
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.061
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.061
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.060
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.060
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.060
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.060
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.060
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.059
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.059
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.059
|
|
|
|
regulation of glomerular mesangial cell proliferation
|
GO:0072124 |
1 |
0.058
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.058
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.057
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.057
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.057
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.057
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.055
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.054
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.054
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.054
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.054
|
|
|
|
gamma delta t cell differentiation
|
GO:0042492 |
11 |
0.054
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.053
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.053
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.053
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.052
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.052
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.052
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.051
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.051
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.051
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.051
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.050
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.050
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.050
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.050
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.050
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.050
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.049
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.049
|
|
|
|
rhombomere 3 development
|
GO:0021569 |
4 |
0.049
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.049
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.049
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.049
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900212 |
4 |
0.049
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.049
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.048
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.048
|
|
|
|
seminiferous tubule development
|
GO:0072520 |
14 |
0.048
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.048
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.048
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.048
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.048
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.047
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.047
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.047
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.047
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.047
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.047
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.047
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.046
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.046
|
|
|
|
diaphragm development
|
GO:0060539 |
5 |
0.046
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.045
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.045
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.045
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.045
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.045
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.045
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.045
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.045
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.045
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.044
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.044
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
13 |
0.044
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.044
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.044
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.044
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.043
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.043
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.043
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.043
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.043
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.042
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.042
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.042
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.042
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.042
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.042
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.042
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.041
|
|
|
|
positive regulation of male gonad development
|
GO:2000020 |
6 |
0.041
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.041
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.041
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.041
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.041
|
|
|
|
positive regulation of integrin mediated signaling pathway
|
GO:2001046 |
5 |
0.041
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.041
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.040
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.040
|
|
|
|
regulation of metanephric ureteric bud development
|
GO:2001074 |
1 |
0.040
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.040
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.039
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.039
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.039
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.039
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.039
|
|
|
|
facial nerve structural organization
|
GO:0021612 |
10 |
0.039
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.039
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.039
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.039
|
|
|
|
thorax and anterior abdomen determination
|
GO:0007356 |
1 |
0.039
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.038
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.038
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.038
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.038
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.038
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.038
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.038
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.038
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.038
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.038
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.037
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.037
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.037
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.037
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.037
|
|
|
|
rhombomere 5 morphogenesis
|
GO:0021664 |
1 |
0.037
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.036
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.036
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.036
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.036
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.036
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.036
|
|
|
|
nuclear export
|
GO:0051168 |
34 |
0.035
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.035
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.035
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.035
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.035
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.035
|
|
|
|
lateral line nerve development
|
GO:0048892 |
1 |
0.034
|
|
|
|
sensory perception of umami taste
|
GO:0050917 |
4 |
0.034
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.034
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.034
|
|
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.034
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.034
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.034
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.034
|
|
|
|
facial nerve development
|
GO:0021561 |
11 |
0.034
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.034
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.034
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.033
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.033
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.033
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.033
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.033
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.033
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.033
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.033
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.033
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.033
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.032
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.032
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.032
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.032
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.032
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.032
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.032
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.032
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.032
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.032
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.032
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.032
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.032
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.031
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.031
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.031
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.031
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
19 |
0.031
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.030
|
|
|
|
regulation of metanephric glomerular mesangial cell proliferation
|
GO:0072301 |
1 |
0.030
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.030
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.030
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.029
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.029
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.029
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.029
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.029
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.029
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.029
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.029
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.028
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.028
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.028
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.028
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.028
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.028
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.028
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.027
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.027
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.027
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.027
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.027
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.027
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.027
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.027
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.027
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.027
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.027
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.027
|
|
|
|
negative regulation of reproductive process
|
GO:2000242 |
31 |
0.027
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.027
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.027
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.026
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.026
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.026
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.026
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.026
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.026
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.026
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.026
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.026
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.026
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.025
|
|
|
|
regulation of gamma delta t cell activation
|
GO:0046643 |
9 |
0.025
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.025
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.025
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.025
|
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.025
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.025
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.025
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.025
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.025
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.025
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.025
|
|
|
|
negative regulation of metanephros development
|
GO:0072217 |
6 |
0.025
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.025
|
|
|
|
gamma delta t cell activation
|
GO:0046629 |
13 |
0.025
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.025
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.025
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.024
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.024
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.024
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.024
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.024
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.024
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.024
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.024
|
|
|
|
regulation of male gonad development
|
GO:2000018 |
7 |
0.024
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.023
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.023
|
|
|
|
translation
|
GO:0006412 |
93 |
0.023
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.023
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.023
|
|
|
|
oocyte maturation
|
GO:0001556 |
18 |
0.023
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.023
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.023
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.023
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.023
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.023
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.023
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.023
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.023
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.023
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.023
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.022
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.022
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.022
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.022
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.022
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.022
|
|
|
|
regulation of t cell differentiation in thymus
|
GO:0033081 |
24 |
0.022
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.022
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.022
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.022
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.022
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.022
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.022
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.022
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.022
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.022
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.022
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.021
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.021
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.021
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.021
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.021
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.021
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.021
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.021
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.021
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.021
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.021
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.021
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.021
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.021
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.021
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.021
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.021
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.021
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.021
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.021
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.021
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.021
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.020
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.020
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.020
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.020
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.020
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.020
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.020
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.020
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.020
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.020
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.020
|
|
|
|
regulation of integrin mediated signaling pathway
|
GO:2001044 |
8 |
0.020
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.020
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.020
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.020
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.020
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.020
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.019
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.019
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.019
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.019
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.019
|
|
|
|
ectoderm development
|
GO:0007398 |
15 |
0.019
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.019
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.019
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.019
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.019
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.019
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.019
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.019
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.019
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.019
|
|
|
|
sertoli cell development
|
GO:0060009 |
15 |
0.019
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.019
|
|
|
|
cranial nerve structural organization
|
GO:0021604 |
13 |
0.019
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.018
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.018
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.018
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.018
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.018
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.018
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.018
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.018
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.018
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.018
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.018
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.018
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.018
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.018
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.018
|
|
|
|
posterior mesonephric tubule development
|
GO:0072166 |
2 |
0.018
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.018
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.018
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.018
|
|
